Drugs, Addiction, and Reward - PowerPoint PPT Presentation

1 / 49
About This Presentation
Title:

Drugs, Addiction, and Reward

Description:

CHAPTER 16 Drugs, Addiction, and Reward Psychoactive Drugs * Figure 5.7 A normal brain and a brain on cocaine The lower two PET scans show greatly decreased activity ... – PowerPoint PPT presentation

Number of Views:407
Avg rating:3.0/5.0
Slides: 50
Provided by: liltIlstu7
Category:

less

Transcript and Presenter's Notes

Title: Drugs, Addiction, and Reward


1
CHAPTER 16
  • Drugs, Addiction, and Reward
  • Psychoactive Drugs

2
Psychoactive Drugs
  • Drug a substance that on entering the body
    changes the body or its functioning.
  • An agonist mimics or enhances the effect of a
    neurotransmitter.
  • An antagonist may occupy the receptors without
    activating them, simultaneously blocking the
    transmitter from binding to the receptors.
  • Psychoactive drugs are those that have
    psychological effects, such as anxiety relief or
    hallucinations.

3
Psychoactive Drugs opiates
  • Opiates
  • derived form the opium poppy.
  • Can also be synthetically made
  • Act on opiate receptors or endorphin receptors
  • Several important effects
  • analgesic (pain relieving)
  • hypnotic (sleep inducing)
  • produce a strong euphoria (sense of happiness of
    ecstasy).
  • Types of opiates
  • Morphine pain relief, surgical pain relief,
    cancer
  • Derivatives include codeine, vicodin, oxycotin,
    etc...
  • Heroin
  • synthesized from morphine
  • marketed as an over-the-counter analgesic until
    its dangers were recognized
  • now it is an illegal drug in the U.S.

4
Opiate drug action
  • Endorphins
  • body produces its own natural opiates, which are
    neuromodulators
  • Released when in pain, motor exertion, stress
  • Endogenous opiates
  • Endogenous made by the body.
  • Opiate drugs are effective because they mimic
    endorphins
  • Because of CNS effects and cognitive effects,
    very high likelihood of abuse.

5
Psychoactive drugs the depressants
  • Depressants
  • drugs that reduce central nervous system
    activity.
  • Sedatives calming drugs
  • Barbiturates including amobarbital (Amytal)
    pentobarbital (Nembutal) secobarbital (Seconal)
    and Phenobarbitol (Luminal)
  • Anxiolytic anxiety-reducing drugs
  • Benzodiazepines ("minor tranquilizers") including
  • Klonopin diazepam (Valium) estazolam (Prosom)
    flunitrazepam (Rohypnol) lorazepam (Ativan)
    midazolam (Versed) nitrazepam (Mogadon)
    oxazepam (Serax) triazolam (Halcion)
    ttemazepam (Restoril , Normison, Planum Tenox,
    Temaze) chlordiazepoxide (Librium)

6
Psychoactive drugs the depressants
  • Hypnotic drugs induce sleep-like states
  • Nonbenzodiazepines
  • Zolpidem Zaleplon Zopiclone Eszopiclone
  • Antihistamines
  • Diphenhydramine Doxylamine Hydroxyzine
    Promethazine
  • Others
  • gamma-hydroxybutyric acid (Xyrem)
  • Glutethimide
  • Chloral hydrate
  • Ethchlorvynol
  • Levomepromazine
  • Chlormethiazole

7
Sedative effects on cns
  • Barbiturates
  • Suppress inhibitory centers
  • in small amounts act selectively on higher
    cortical centers, especially those involved in
    inhibiting behavior
  • In low doses
  • produce talkativeness
  • increased social interaction,
  • Higher doses
  • sedatives and hypnotics.
  • Barbiturates do not reduce pain, but they do
    reduce the anxiety associated with pain.
  • Barbiturates produce their effects by decreasing
    glutamate activity and increasing GABA activity.
  • They operate at the barbiturate receptor on the
    GABAA complex.

8
Benzodiazepines- an alternative to barbiturates?
  • A few decades ago
  • Barbiturates drug of choice for treating
    anxiety
  • Also as most common drug for situations requiring
    sedation.
  • BUT high liability
  • potential for addiction
  • High rate of accidental or intentional death.
  • Benzodiazepines largely replaced barbiturates
  • produce anxiety reduction,
  • Also induce sedation and muscle relaxation.
  • operate at the benzodiazepine receptor on the
    GABAA complex.
  • At first, thought non-addictive
  • Today know that are highly addictive

9
Psychoactive drugs Alcohol
  • Ethanol, or alcohol
  • is a drug
  • fermented from fruits, grains, and other plant
    products.
  • Is a DEPRESSANT
  • It acts at many brain sites to produce euphoria,
    anxiety reduction, sedation, motor
    incoordination, and cognitive impairment
  • Why is it a depressant?
  • Depresses CNS
  • Inhibits areas of the brain that inhibit acting
    out, inappropriate behavior, etc..

10
How does alcohol affect the CNS?
  • Alcohol inhibits the release of glutamate (the
    most prevalent excitatory neurotransmitter).
  • glutamate reduction produces a sedating effect
  • Chronic use results in a compensatory increase
    in glutamate receptors,
  • probably accounts for the seizures that sometimes
    occur during withdrawal.
  • Alcohol also increases the release of
    gamma-aminobutyric acid (GABA
  • the most prevalent inhibitory neurotransmitter).
  • Alcohol specifically affects the A subtype of
    GABA receptor.
  • The combined effect at these two receptors is
  • sedation,
  • anxiety reduction,
  • muscle relaxation,
  • inhibition of cognitive and motor skills.

11
(No Transcript)
12
Alcohol abuse effects
  • Cirrhosis of the liver,
  • Common side effect of chronic alcoholism
  • in its severest form is fatal.
  • Vitamin B1 deficiency
  • associated with chronic alcoholism
  • can produce brain damage and Korsakoffs syndrome
  • Korsakoffs syndrome
  • Neurological syndrome due to alcohol damage, B1
    deficiency
  • involves severe memory loss along with sensory
    and motor impairment.
  • Alcohol withdrawal symptoms
  • involves tremors, anxiety, and mood and sleep
    disturbances
  • Delirium tremors
  • more severe reactions
  • hallucinations, delusions, confusion, and in
    extreme cases, seizures
  • possible death.

13
(No Transcript)
14
Psychoactive stimulants
  • Stimulants
  • activate the central nervous system to produce
  • arousal,
  • increased alertness,
  • elevated mood
  • Typically affect dopamine, norepinephrine and
    serotonin
  • Several drugs in this category
  • Cocaine
  • Amphetamine
  • Methamphetamine
  • Ritalin
  • Adderal,
  • Most ADHD medications
  • Ephedrine

15
Psychoactive stimulants
  • Cocaine,
  • extracted from the South American coca plant,
  • produces
  • Euphoria
  • decreases appetite,
  • increases alertness
  • relieves fatigue.
  • Cocaine blocks the reuptake of dopamine and
    serotonin at synapses,
  • Potentiating effect of these neurotransmitters
  • Makes neurotransmitter remain longer in synapse.
  • Presumably, cocaine produces euphoria and
    excitement because dopamine removes the
    inhibition the cortex usually exerts on lower
    structures.

16
Cocaine user
Normal
17
Psychoactive Drugs
  • Amphetamines
  • group of synthetic drugs
  • Again produce euphoria
  • increase confidence
  • concentration.
  • increase the release of norepinephrine and
    dopamine
  • Common examples
  • Amphetamine (Adderal) Dextroamphetamine
    (Dexedrine, Dextrostat)
  • Methamphetamine (Desoxyn)
  • Highly relatedRitalin
  • Ritalina, Rilatine, Attenta, Methylin, Penid,
    Rubifen) and the sustained release tablets
    Concerta, Metadate CD, Methylin ER, Ritalin LA,
    and Ritalin-SR. Focalin

18
Amphetamine Action
  • DA neurons release DA into the synapse From
    there 1 of 3 things can happen
  • DA can then attach to the post-synaptic membrane
  • DA can be degraded by enzymes
  • DA can be taken back up by the pre-synaptic
    membrane.
  • Amphetamine appears to affect all three
    mechanisms
  • Promotes release of DA into the synapse
  • Inhibits the DA degredative enzyme, monoamine
    oxidase (MAO),
  • Blocks the uptake proteins in the pre-synaptic
    membrane
  • The result Amphetamine effectively promotes a
    flood of DA into the brain reward center
  • Nucleus Accumbens or Nac
  • This area is highly involved in both learning and
    reward.

19
Amphetamine Action
  • Amphetamine and related compounds elicit a
    variety of dose-dependent deleterious effects.
  • low doses of AMPH may improve attention and
    vigilance
  • improve vigilance
  • At high doses over-stimulation of the motor and
    cognitive systems
  • behavioral stereotypy, repetitive thoughts and
    even hallucinations.
  • In rodents, a high AMPH dose elicits behavioral
    stereotypy
  • continuous digging Searching Licking Gnawing
    Circling
  • In humans, high doses of AMPH may elicit
  • psychotic state,
  • High rates of locomotion and repetitive behavior
  • high potential for self-injury or injury to
    others

20
A normally moving rat
21
A rat given 8.0 mg/kg amphetamine
22
Psychoactive Drugs Nicotine
  • Nicotine
  • primary psychoactive and addictive agent in
    tobacco
  • Also in chewing tobacco, nicotine gum, etc.
  • It stimulates nicotinic acetylcholine receptors.
  • In the periphery,
  • it activates muscles
  • may cause twitching.
  • In CNS
  • produces increased alertness
  • Also faster response to stimulation.

23
Psychoactive Drugs Caffeine
  • Caffeine
  • active ingredient in coffee, many soda pops
    teas energy drinks, etc.
  • produces arousal, increased alertness, and
    decreased sleepiness.
  • Action blocks receptors for the neuromodulator
    adenosine
  • This increases the release of dopamine and
    acetylcholine.
  • Because adenosine has sedative and depressive
    effects, blocking its receptors contributes to
    arousal
  • Acts like amphetamine in releasing DA.

24
Psychodelic Drugs
  • Psychedelic drugs
  • compounds that cause perceptual distortions in
    the user.
  • May be referred to as hallucinogenic
  • Not really inducing hallucinations, but
    distortions in perception
  • Light and color details are intensified,
  • objects may change shape,
  • sounds may evoke visual experiences,
  • light may produce auditory sensations.

25
Psychoactive Drugs
  • lysergic acid diethylamide (LSD)
  • best-known psychedelic
  • is structurally similar to serotonin
  • stimulates serotonin receptors
  • Appears to disrupt the brain stems ability to
    screen out irrelevant stimuli.
  • psilocybin and psilocin
  • Another serotonin-like psychedelics
  • both derived from the mushroom, Psilocybe
    mexicana
  • Mescaline
  • the active ingredient in peyote (the crown or
    button on the top of the peyote cactus),
  • psychedelic properties result from stimulation of
    serotonin receptors.

26
Psychoactive Drugs Ecstasy
  • Ecstasy
  • street name for a drug developed as a weigh-loss
    compound
  • methlenedioxymethamphetamine (MDMA).
  • At low doses
  • psychomotor stimulant
  • Increases energy, sociability, and sexual
    arousal.
  • At higher doses
  • produces hallucinatory effects like LSD.
  • Also can overstimulate muscles resulting in
    locked or frozen muscles
  • MDMA stimulates
  • the release of dopamine which accounts for muscle
    and arousal effects
  • the release of serotonin, which probably accounts
    for the hallucinatory effects.

27
These brain sections have been stained with a
chemical that makes neurons containing serotonin
turn white. Photos in the top row are from a
normal monkey those below are from a monkey
given MDMA a year earlier.
28
Psychoactive Drugs PCP
  • Phencyclidine (PCP)
  • Developed as an anesthetic typically used by
    veterinarians
  • was abandoned for human use because it produces
    schizophrenia-like disorientation and
    hallucinations.
  • PCP increases activity in the dopamine pathways
  • This stimulates motivation system
  • Also, drugs motivating properties apparently are
    partly due to its inhibition of a subtype of
    glutamate receptors.

29
marijuana
  • Marijuana
  • is the dried and crushed leaves and flowers of
    the Indian hemp plant, Cannabis sativa.
  • The major psychoactive ingredient is
    delta-9-tetrahydrocannabinol (THC)
  • .
  • THC actions
  • THC binds with cannabinoid receptors, which
    ordinarily respond to endogenous cannabinoids.
  • Two known cannabinoids receptors
  • anadamide
  • 2-arachidonyl glycerol, or 2-AG.
  • These receptors are found on axon terminals
  • Unusual action
  • cannabinoids are released by postsynaptic neurons
  • act as retrograde messengers, regulating the
    presynaptic neurons release of neurotransmitter.

30
Addiction
  • Reward refers to the positive effect an object or
    condition such as a drug, food, sexual contact,
    and warmth has on the user.
  • Drug researchers have traditionally identified
    the mesolimbicortical dopamine system as the
    location of the major drug reward system.
  • It takes its name from the fact that it begins in
    the midbrain (mesencephalon) and projects to the
    limbic system and prefrontal cortex.
  • The most important structures in the system are
    the nucleus accumbens, the medial forebrain
    bundle, and the ventral tegmental area.

31
Virtually all the abused drugs increase dopamine
levels in the nucleus accumbens
32
Psychoactive Drugs
  • Addiction
  • preoccupation with obtaining a drug
  • compulsive use of the drug in spite of adverse
    consequences
  • high tendency to relapse after quitting
  • Typically defined as an individual showing both
    withdrawal and tolerance.
  • Withdrawal
  • negative reaction that occurs when drug use is
    stopped
  • Bodys compensatory reaction.
  • Tolerance
  • individual becomes less responsive to the drug
  • requires increasing amounts of the drug to
    produce the same results.

33
Addiction
  • Societal definition
  • obsession, compulsion, or excessive physical
    dependence or psychological dependence,
  • E.g., drug addiction, alcoholism, compulsive
    overeating, problem gambling, computer addiction,
    pornography, etc.
  • Scientific definition of Addiction A state in
    which
  • the body relies on a substance for normal
    functioning and develops physical dependence
  • When the drug or substance on which someone is
    dependent is suddenly removed, it will cause
    withdrawal,
  • increased drug tolerance.
  • However, common usage spread to include
    psychological dependence, but brain doesnt
    recognize this distinction

34
Addiction
  • Addiction and withdrawal take place in different
    parts of the brain and are independent of each
    other.
  • The ventral tegmental area is suggested to be
    involved in addiction,
  • Periventricular gray area produces classic signs
    of withdrawal.
  • Not mean that addicts never take drugs to avoid
    withdrawal symptoms,
  • Means that withdrawal is not necessary for
    addiction and avoidance of withdrawal is not an
    explanation of addiction.

35
Addiction pathways
36
Addiction involves Dopaminergic pathway
  • mesolimbicortical dopamine system
  • Major reward system
  • Many drugs (especially stimulants) mimic effects
    of normal reward.
  • begins in the midbrain (mesencephalon) and
    projects to the limbic system and prefrontal
    cortex.
  • The most important structures in the system
  • nucleus accumbens
  • medial forebrain bundle
  • ventral tegmental area.

37
Reward and the Dopaminergic pathway
  • Schultz (2005) and others show
  • Dopamine is not released as a reward
  • Dopamine is a motivating neurotransmitter-
    produces increases in locomotion, action behavior
    that is oriented towards reward
  • Thus when dopamine released, body moves towards
    or continues doing whatever it was doing to keep
    getting that Reward
  • General DA reward system serves as feedback
    system that identifies
  • need to continue or shift behavior depending on
    reward situation
  • Helps select the appropriate response for the
    situation

38
Changing behavior with DA agonists
  • Virtually all the abused drugs increase dopamine
    levels in the nucleus accumbens.
  • Electrical stimulation of the brain (ESB),
  • Stimulate Nucleus accumbens
  • Animals press a level or engage in high rates of
    locomotion immediately after receiving
    stimulation
  • Why? DA release elicits search behavior
  • A reinforcer is any object or event that
    increases the probability of the response that
    precedes it
  • Thus, must keep doing the behavior that got you
    the reinforcer
  • DA maintains ongoing responses or kicks you into
    movement behaviors that increase likelihood of
    reward.

39
Changing behavior with DA agonists
  • Think of symptoms of stimulant abuse/addiction
  • Lots of motor movement
  • Lots of perseverative motor behavior
  • Nose wiping
  • Tics
  • Perseveration
  • Paranoia is highly similar to schizophrenia
  • Why? Too much dopamine is overstimulating
    circuits, cognitive areas of brain are
    hyperstimulated.
  • What got you these feelings- the drug
  • What do to keep these feelings- get more drug
  • And, because you have replaced normal DA levels,
    now you will engage in seeking behaviors to
    maintain those levels!

40
Diminished dopamine?
  • Chronic drug users show diminished DA release
    from DA receptors
  • May be individual, and not the addiction
  • Lower levels of D2 autoreceptors
  • Note that those with high number of D2
    autoreceptors find DA drugs unpleasurable those
    with fewer report more pleasure
  • D2 autoreceptors help regulate general DA tone in
    synapse, regulate reuptake and production of DA
  • Thus, may be that DA-drug addicts have reward
    deficiency syndrome insufficient receptors to
    respond to DA, need more DA to get same effect

41
Step down reflex
  • Addiction learning
  • Learning produces changes in the brain
  • Addiction produces same changes
  • Drug release of DA
  • US(drug)? UR(drug effects)
  • Stimulus (CS) predicts drug that releases DA
  • CS(cue? US(drug)? UR(drug effects)
  • Anticipate DA release BUT Body prefers
    homeostasis no sudden changes, maintain level
  • CS(cue? US(drug)? UR(drug effects)
  • \
  • ?CR(decrease DA release in anticipation of drug
    DA release)
  • Thus body REDUCES dopamine in ANTICIPATION of
    increase in DA

42
Compensation tolerance and withdrawal
  • Body REDUCES dopamine in ANTICIPATION of increase
    in DA
  • No longer get same effect for drug
  • Must take more
  • This is called tolerance
  • If stop taking the drug, no step-down reflex or
    compensation
  • Now, reduction in DA
  • Now have too little DA shaky, motor tremors,
    etc.
  • This is called withdrawal Setting cues are
    critically important

43
PET scans are shown at two depths in the brain.
Notice the increased activity during presentation
of cocaine-related stimuli. Frontal areas (DL,
MO) and temporal areas (TL, PH) are involved in
learning and emotion.
44
Evidence for Addiction?
  • Nora Volkow and her colleagues, among others
  • Transition from controlled drug use to compulsive
    drug intake involves pathological changes in
    communication between prefrontal cortex and the
    nucleus accumbens.
  • addict returns to drug taking when stress or
    drug-related stimuli trigger increases in
    dopamine release in the prefrontal cortex and
    glutamate release in the nucleus accumbens.
  • Prefrontal release produces a compulsive focus on
    drugs at the expense of other reinforcers
  • Glutamate release cranks up the drive to engage
    in drug seeking.

45
Treating Addiction
  • Agonist treatments replace an addicting drug with
    another drug that has a similar effect.
  • Opiate addiction is often treated with a
    synthetic opiate called methadone.
  • Antagonist treatments involve drugs that block
    the effects of the addicting drugs.
  • Drugs that block opiate receptors are used to
    treat opiate addictions and alcoholism because
    they reduce the pleasurable effects of the drug.
  • Antabuse for alcohol
  • Another experimental strategy is to interfere
    with the dopamine reward system.
  • Baclofen reduces dopamine activity in the ventral
    tegmental area by activating GABAB receptors on
    dopaminergic neurons.

46
(No Transcript)
47
The Role of Genes in Addiction
  • If genetics plays such an important role in
    addiction, just what is inherited?
  • Most research on the genetics of addiction
    implicates various neurotransmitter systems.
  • Appears to be a syndrome or related group of
    dysfunction
  • Addicts correlated with individuals who have
    family members with
  • Schizophrenia, bipolar disorder, depression
  • ADHD and related disorders
  • Autism and autism-spectrum disorders.

48
The Role of Genes in Addiction
  • Dopamine is one of the factors differentiating
    addictive from normal behavior.
  • There are several alleles, or alternate forms, or
    the gene responsible for the development of the
    D2 subtype of dopamine receptor.
  • Various alleles are associated with alcoholism,
    cocaine dependence, stimulant abuse, and multiple
    addictions.
  • Serotonin is involved in drug abuse in general
  • Also in mood,
  • sexual behavior,
  • aggression,
  • the regulation of bodily rhythms and food and
    water intake.
  • Bottom line May have a predisposition
  • Stress bring out or turns on different coping
    mechanism
  • Best way to avoid reduce stress avoid
    situations with drug availability

49
A Societal comment on drug usage from the onion!
  • And now for something absolutely silly!
  • http//www.theonion.com/content/video/fda_approves
    _depressant_drug_for
Write a Comment
User Comments (0)
About PowerShow.com